Patients with neuroendocrine tumours (NETs) are best managed in a specialist centre as
part of a multidisciplinary team comprising gastroenterologists, oncologists …

Neuroendocrine carcinomas are rare neoplasms although of increasing incidence and
concern. While traditionally considered of indolent nature, once they progress beyond …

Neuroendocrine tumours of the gastroenteropancreatic axis include carcinoid tumours and
islet cell tumours of the pancreas (pancreatic endocrine tumours). Standard medical …

Neuroendocrine tumours (NET) of the digestive tract comprise a broad range of
malignancies. The therapeutic approach to these tumours has not evolved as it did in other …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of
neoplasms arising from the diffuse neuroendocrine system. The incidence of GEP-NETs has …

Neuroendocrine tumors (NET) are frequently diagnosed late and not amenable to curative
surgery due to metastatic disease to the liver and lymph nodes. The disease is complex and …

Neuroendocrine tumors (NETs) in general and specifically these gastroenteropancreatic-
neuroendocrine tumors often present a considerable diagnostic and therapeutic challenge …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are more common than
previously thought and second only to colorectal cancers as the most prevalent …

Neuroendocrine (NE) gastroenteropancreatic tumors are a heterogeneous group of
neoplasias arising from neuroendocrine cells of the embryological gut. Their incidence have …

Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) represents a various
family of rare tumours. Surgery is the first choice in GEP-NENs patients with localized …